Complement and meningococcal infection.
- 3 April 1976
- Vol. 1 (6013) , 797-799
- https://doi.org/10.1136/bmj.1.6013.797
Abstract
Serum C3 levels were measured in 211 patients with meningococcal disease. Low levels were found in 13 patients with acute meningococcaemia, and complement activation may have contributed to the peripheral circulatory collapse that was responsible for nine deaths. The complement profile of these patients suggested activation of both classical and alternative complement pathways. Patients with meningitis had a higher mean serum C3 level than controls. Serial studies in 13 serum antigen-positive patients with meningitis who subsequently developed arthritis or cutaneous vasculitis showed a transient fall in serum C3 in eight. This fall was probably due to the formation of immune complexes that were responsible for their allergic complications.Keywords
This publication has 11 references indexed in Scilit:
- Activation of the Properdin Pathway of Complement in Patients with Gram-Negative BacteremiaNew England Journal of Medicine, 1975
- Complement activation in children with acute malaria.1974
- Activation of the Classic and Alternate Complement Pathways by EndotoxinThe Journal of Immunology, 1974
- The Potential Pathogenic Role of Complement in Dengue Hemorrhagic Shock SyndromeNew England Journal of Medicine, 1973
- Allergic Complications of Meningococcal Disease II--Immunological InvestigationsBMJ, 1973
- Interactions of the Classical and Alternate Complement Pathway with Endotoxin Lipopolysaccharide EFFECT ON PLATELETS AND BLOOD COAGULATIONJournal of Clinical Investigation, 1973
- Serum Complement Levels in Bacteremia Due to Gram-Negative OrganismsNew England Journal of Medicine, 1973
- Group-Specific Polysaccharide Antigen and Humoral Antibody Response in Disease due to Neisseria meningitidisThe Journal of Infectious Diseases, 1972
- The Pathogenesis of Arthritis Associated with Viral HepatitisNew England Journal of Medicine, 1971
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969